
ANGFA FEMCHA Flora Protect Supplement, 30 tablets
30,18€
* Prices include VAT and possibly plus shipping costs. Details about shipping can be found here.
About product
Preparation for supporting women’s health
-
Description
Description
Femcha Flora Protect Supplement is an innovative Japanese dietary supplement developed to support women’s health and maintain a healthy vaginal microflora balance. Suitable for daily use during various stages of life — from hormonal fluctuations to menopause and conception preparation.
Key Features- Double Probiotic Power: Each capsule delivers 10 billion live cells of two clinically studied strains: Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. These probiotics help restore and maintain healthy vaginal flora, reducing the risk of odour, itching and discomfort.
- Multi-Stage Support: Recommended for women during menopause, pre-pregnancy care, or those experiencing discomfort due to microflora imbalance.
The GR-1 and RC-14 probiotic strains survive digestion, reach the vaginal area via the gut, and help balance beneficial and conditionally pathogenic bacteria. This supports the body’s natural defences, helps prevent inflammation, and combats odours and itching in the intimate area.
How to Take- Take 1 capsule per day with water.
- Can be taken at any time of the day, with or without food.
- Do not exceed the recommended daily dose.
- Not intended for children.
- Do not take if allergic to any ingredients.
- If you are pregnant, breastfeeding, on medication or have a chronic condition, consult your doctor before use.
- This product is not a medicine and does not replace a balanced diet.
Manufacturer: ANGFA Co., Ltd. (アンファー株式会社)
Customer Support: 0120-059-595 (9:00–18:00 JST, except Sundays & holidays) -
Additional information
Additional information
Weight 40 g Suitable for Purpose -
Reviews (0)
Be the first to review “ANGFA FEMCHA Flora Protect Supplement, 30 tablets” Cancel reply
You must be logged in to post a review.
You May Also Like

Reviews
There are no reviews yet.